MNKD earnings date and last-quarter result: last quarter miss, P/E -49.68. Updated 2026-07-23.
MannKind (MNKD) Research Hub
MannKind (MNKD) trades on NASDAQ, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 3.23 USD (+1.25%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -49.68, market cap 1.20B. This hub links to the full technical, earnings and options research available for MNKD.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 3.23 USD (+1.25%) |
| 52-week range | 2.895 USD – 4.55 USD |
| Trend regime | Range |
| 14-day RSI | 31.8 (Bearish) |
| Trailing P/E | -49.68 |
| Market cap | 1.20B |
| Dividend yield | 0.00% |
Available research for MNKD
Covered Call on MNKD: how it works, illustrative setup around the real 3.23 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on MNKD: how it works, illustrative setup around the real 3.23 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on MNKD: how it works, illustrative setup around the real 3.23 USD price, max profit/loss, breakeven and when to use it. Educational.
MNKD technical analysis: range, last 3.23 USD, RSI 31.8, 52w range 2.895 USD–4.55 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is MNKD in?
MannKind (MNKD) is classified under Healthcare (Biotechnology), listed on NASDAQ, US.
Is MNKD in an uptrend or downtrend?
As of 2026-10-26, MNKD is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is MNKD's trailing P/E ratio?
MNKD's trailing P/E is -49.68, with a market cap of 1.20B. See the earnings research page for full valuation detail.